" class="no-js "lang="en-US"> Huma Archives - Medtech Alert
Friday, April 12, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Huma and UCB to Provide Digital Health Solution for Myasthenia Gravis

Huma Therapeutics, a leading global digital health company, and UCB, a global biopharmaceutical company, are […]

Huma, Camden Health Partners and UCLPartners launch digital-first population health programme to identify and manage cardiovascular disease

Huma Therapeutics, a leading global digital health company, today announced a partnership with Camden Health […]

Huma Joins Forces With Independent Healthcare Provider to Launch Virtual Ward Service for the NHS

Huma are partnering with Xyla Elective Care, a national provider of NHS England-funded elective services, […]

Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care

Huma Therapeutics Limited, a global digital health technology company advancing digital-first care delivery and research […]

Huma Raises $130 Million Financing to Scale its Digital Health Platform for Better Care and Research

Huma Therapeutics Limited today announces the completion of its latest funding round with financing of approximately […]

Huma and RARE-X Partner to Accelerate Research for 9,500 Rare Diseases

Huma, Europe’s fastest-growing health technology company, is partnering with the non-profit patient advocacy group RARE-X, which runs […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more